| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,442 |
5,190 |
$209K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,180 |
5,708 |
$145K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
10,783 |
4,054 |
$126K |
| 95144 |
|
267 |
186 |
$91K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,092 |
1,091 |
$61K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
898 |
889 |
$48K |
| 94010 |
|
4,637 |
4,482 |
$41K |
| 95117 |
|
14,972 |
5,687 |
$19K |
| 99243 |
|
536 |
532 |
$14K |
| 94060 |
|
636 |
634 |
$12K |
| 94664 |
|
1,772 |
1,708 |
$6K |
| 94200 |
|
8,011 |
3,845 |
$6K |
| 95012 |
|
279 |
276 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
64 |
64 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
423 |
423 |
$611.51 |
| 99072 |
|
760 |
439 |
$550.16 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
310 |
300 |
$14.12 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
13 |
$10.29 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
304 |
303 |
$8.86 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
38 |
38 |
$0.00 |